Xtant Medical Holdings Analyst Price Targets - Benzinga

Xtant Medical Holdings Inc

XTNTAMEX

Trade with Public

Trade with Public

$0.3840

0.05416.36%

가까이에: Aug 28, 5:00 PM EST

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 주식 보고서

Xtant Medical Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Xtant Medical Holdings (XTNT).

Price Target Range — 5 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$1

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 13, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$1
Mar 31, 2026	BTIG	Ryan Zimmerman	PT Cut	Buy	$2→$1
Nov 11, 2025	BTIG	Ryan Zimmerman	PT Cut	Buy	$2→$2
May 16, 2024	BTIG	Ryan Zimmerman	PT Raise	Buy	$2→$3
Dec 5, 2023	BTIG	Ryan Zimmerman	Initiate	Buy	$2

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Reiterates Buy on Xtant Medical Holdings, Maintains $1 Price Target

BTIG analyst Ryan Zimmerman reiterates Xtant Medical Holdings (AMEX:XTNT) with a Buy and maintains $1 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the price target from $1.5 to $1.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1.5

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the price target from $2 to $1.5.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Xtant Medical Hldgs, Raises Price Target to $3

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and raises the price target from $2 to $3.

Benzinga Newsdesk

PRO
BTIG Initiates Coverage On Xtant Medical Hldgs with Buy Rating, Announces Price Target of $2

BTIG analyst Ryan Zimmerman initiates coverage on Xtant Medical Hldgs (AMEX:XTNT) with a Buy rating and announces Price Target of $2.

Benzinga Newsdesk

PRO
Craig-Hallum Maintains Buy on Xtant Medical Hldgs, Raises Price Target to $1.2

Craig-Hallum analyst Chase Knickerbocker maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and raises the price target from $1 to $1.2.

Benzinga Newsdesk